Global Biomarker Technologies Market to reach USD 108 billion by 2026

Global Biomarker Technologies Market Size study, by Product (Consumables, Service), Type ( Safety, Efficacy, Validation), Disease Indication (Cancer, Cardiovascular Diseases), Application (Diagnostics Development, Drug Discovery & Development, Disease-Risk) and Regional Forecasts 2019-2026
Product Code:  HALB_27901525

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Biomarker Technologies Market, by Product, 2016-2026 (USD Billion)
1.3.2. Biomarker Technologies Market, by Type, 2016-2026 (USD Billion)
1.3.3. Biomarker Technologies Market, by Disease Indication, 2016-2026 (USD Billion)
1.3.4. Biomarker Technologies Market, by Application, 2016-2026 (USD Billion)
1.3.5. Biomarker Technologies Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biomarker Technologies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biomarker Technologies Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Biomarker Technologies Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Biomarker Technologies Market by Product
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Biomarker Technologies Market, Sub Segment Analysis
5.3.1. Consumables
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2. Services
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Global Biomarker Technologies Market by Type
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Biomarker Technologies Market, Sub Segment Analysis
6.3.1. Safety
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Efficacy
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3. Validation
6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Global Biomarker Technologies Market by Disease Indication
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Biomarker Technologies Market, Sub Segment Analysis
7.3.1. Cancer
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Cardiovascular Disorders
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Global Biomarker Technologies Market by Application
8.1. Market Snapshot
8.2. Market Performance – Potential Model
8.3. Biomarker Technologies Market, Sub Segment Analysis
8.3.1. Diagnostics Development
8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2. Drug Discovery & Development
8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3. Disease Risk
8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9. Global Biomarker Technologies Market, by Regional Analysis
9.1. Biomarker Technologies Market, Regional Market Snapshot (2016-2026)
9.2. North America Biomarker Technologies Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3. Europe Biomarker Technologies Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3. Rest of Europe
9.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4. Asia Biomarker Technologies Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5. Latin America Biomarker Technologies Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6. Rest of The World
9.6.1. Middle East and Africa
9.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.3. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.4. Disease Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.5. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 10. Competitive Intelligence
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Qiagen N.V.
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. PerkinElmer Inc
10.3.3. Merck Milipore
10.3.4. Bio-rad Laboratories Inc
10.3.5. Enzo Biochem Inc
10.3.6. Biosims Technologies SAS
10.3.7. Cisbio Bioassays
10.3.8. Thermo Fisher Scientific
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.1.6. Research Assumption

Global Biomarker Technologies Market is valued approximately USD 51.5 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 9.70% over the forecast period 2019-2026. A biomarker is referred as a biological marker which is gene or molecule by which the biological state of the individual body is precisely measured in order to assess & predict the impact of the diseases or the physiological state of the individual. The Key factors which give growth to the Biomarker technologies market are increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research. On the other hand, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage are the major factors restraining the growth of this market.

The regional analysis of global Biomarker Technologies market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging diagnostic applications of biomarkers, surging research & development funding for pharma & biotech organizations and escalating number of cros. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising number of clinical trials and escalating number of infectious diseases create lucrative growth prospects for the Biomarker Technologies market across Asia-Pacific region.

Major market player included in this report are:
Thermo Fisher Scientific Inc
Qiagen N.V.
Perkinelmer Inc
Merck Milipore
Bio-Rad Laboratories Inc
Enzo Biochem Inc
Biosims Technologies SAS
Cisbio Bio Assays
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Service
By Type:
Safety
Efficacy
Validation
By Disease Indication:
Cancer
Cardiovascular Disorders
By Application:
Diagnostics Development
Drug Discovery & Development
Disease Risk

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Biomarker Technologies Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…